Archives

by in
Entry Author Date Location
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
Juno Therapeutics Adds Jeff Bezos, Venrock to $145M Venture Deal 01/13/14 Seattle
Blueprint Medicines Hauls in $25M For Cancer Drug Push 01/07/14 Boston
A Revolution is Taking Place in the Treatment of Blood Cancers 12/16/13 National
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square 12/04/13 New York
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
Ariad Pulls Cancer Drug Off the Market as Trial Fallout Continues 10/31/13 Boston
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
Austin Startup Savara Wins Research Award for CF Therapy 10/17/13 Texas
Ariad Halts Leukemia Drug Trials Due to Safety Concerns, Shares Plummet 10/09/13 Boston
Boston’s Life Science Disruptors: The Photos 10/07/13 Boston
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
Are Some Degrees Better than Others for Big Pharma Leaders? 09/09/13 Seattle
Aileron Goes After Cancer’s Hard Target, P53, With Peptide Drug 09/03/13 Boston
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More 08/09/13 New York
Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs 08/06/13 Boston
Why Deborah Dunsire’s Unusual Bet on Alzheimer’s Makes Sense 07/31/13 Boston
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Biogen’s Oral MS Drug Tops Estimates, Brings in $192M in First Quarter 07/25/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
Ex-Prometheus Exec Takes the Reins at Dallas’ Gradalis 07/23/13 Texas
Page 2 of 13 « previous page · next page »